These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 10788220)
1. Race for perfection: children's rights and enhancement drugs. Powers T J Law Health; 1998-1999; 13(1):141-69. PubMed ID: 10788220 [No Abstract] [Full Text] [Related]
2. [Attention deficit disorder with hyperactivity (ADHD). Continuing symptom control with medium term methylphenidate treatment]. Oberpichler-Schwenk H Med Monatsschr Pharm; 2006 Nov; 29(11):415-6. PubMed ID: 17131689 [No Abstract] [Full Text] [Related]
4. ADHD drugs and cardiovascular risk. Wojnowski L N Engl J Med; 2006 May; 354(21):2296-8; author reply 2296-8. PubMed ID: 16729376 [No Abstract] [Full Text] [Related]
5. Drugs and children. Pinkham JR ASDC J Dent Child; 2002; 69(1):10. PubMed ID: 12119805 [No Abstract] [Full Text] [Related]
6. Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder. Pae CU Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1149-50; author reply 1151-2. PubMed ID: 17493730 [No Abstract] [Full Text] [Related]
7. Methylphenidate use and divorce. Schultz BK CMAJ; 2007 Sep; 177(7):751; author reply 751. PubMed ID: 17893352 [No Abstract] [Full Text] [Related]
8. [Attention deficit-hyperactivity disorder (ADHD); etiology, diagnosis and treatment]. 't Jong GW; van den Anker JN Ned Tijdschr Geneeskd; 2000 Nov; 144(46):2227-8. PubMed ID: 11103263 [No Abstract] [Full Text] [Related]
9. [The use of methylphenidate in children with ADHD]. Lauth B Laeknabladid; 2007 Dec; 93(12):823. PubMed ID: 18057471 [No Abstract] [Full Text] [Related]
10. Increased urine phenylethylamine after methylphenidate treatment in children with ADHD. Kusaga A; Yamashita Y; Koeda T; Hiratani M; Kaneko M; Yamada S; Matsuishi T Ann Neurol; 2002 Sep; 52(3):372-4. PubMed ID: 12205654 [TBL] [Abstract][Full Text] [Related]
11. [Hyperkinetic syndrome and dyslexia. Medical help for the hyperactive child]. Stiefelhagen P MMW Fortschr Med; 2002 May; 144(21):4-8. PubMed ID: 12134423 [No Abstract] [Full Text] [Related]
13. Evidence and belief in attention deficit hyperactivity disorder. Reintroduction of methylphenidate in Italy needs careful monitoring. Bonati M; Impicciatore P; Pandolfini C BMJ; 2001 Mar; 322(7285):556. PubMed ID: 11263458 [No Abstract] [Full Text] [Related]
14. [Central stimulants in the treatment of children with ADHD: unknown long-term effect and uncertain pharmacological documentation]. Zetterström R Lakartidningen; 2002 Feb; 99(7):677-80. PubMed ID: 11887717 [No Abstract] [Full Text] [Related]
15. [After the researchers have left the field]. Boer F Tijdschr Psychiatr; 2007; 49(8):525-7. PubMed ID: 17824135 [No Abstract] [Full Text] [Related]
16. Transdermal methylphenidate (Daytrana) for ADHD. Med Lett Drugs Ther; 2006 Jun; 48(1237):49-51. PubMed ID: 16785850 [No Abstract] [Full Text] [Related]
17. [The costs of drugs against ADDH should be reduced]. Rise L Lakartidningen; 2003 Jun; 100(26-27):2316; author reply 2316. PubMed ID: 12872384 [No Abstract] [Full Text] [Related]
18. ADHD, Ritalin, and big brother. Miller AL Altern Med Rev; 2000 Oct; 5(5):401. PubMed ID: 11056410 [No Abstract] [Full Text] [Related]
20. [Methylphenidate. A drug for attention deficit disorders to be used with precaution]. Taéron C Rev Infirm; 2009 Jun; (151):47-9. PubMed ID: 19579855 [No Abstract] [Full Text] [Related] [Next] [New Search]